Latest News
Clinical Trial Results 23 October 2026
The clinical trial results 23 October 2026 cover non-infectious uveitis, hidradenitis suppurativa, IgA nephropathy, wet AMD and metastatic colorectal cancer. Priovant’s brepocitinib met its primary endpoint in two Phase 3 trials in non-infectious uveitis. AbbVie’s...
Latest News
ACTO Achieves Veeva Gold Product Partner Status
Validated integrations with Veeva applications help life sciences field teams train, practice, and execute with approved content and real time intelligence Toronto and New York, 2 September 2026 ACTO, uniting human intelligence with empathetic AI in life sciences,...
Huntington Gene Therapy Submission Reaches FDA and MHRA
uniQure filed for regulatory approval of its Huntington’s disease gene therapy on 2 September 2026. The Huntington gene therapy submission went to two agencies. One is the US Food and Drug Administration. The other is the UK Medicines and Healthcare products...
GLP-1 Indications: The 2026 Regulatory Status Map
The list of approved GLP-1 indications now reaches well beyond weight loss and glycaemic control. Regulators in three major markets have licensed the class across cardiology, nephrology and hepatology. Other conditions carry positive phase 3 data but no licence at...
AI in MedTech: Accelerating the Product Development Lifecycle
Developing a new medical device is a lengthy, complex process that typically takes between three to seven years from conception to market [1]. For MedTech companies operating within highly regulated environments where compliance and patient safety are paramount,...
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters, all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
Australian Healthcare Reviews Mean Nothing Without the Right Governance
Australians are making some of their most important healthcare decisions based on information that was never designed to carry that weight. For most Australians, searching for health information online and accessing test results digitally is already routine. Around 90...
GMCA: Why Unlocking Longevity Research Will Drive Innovation
The science of longevity has never been more active. With advances in preventive medicine and digital health, as well as new insights into lifestyle, environment, drug therapies and genetics, there is more research available than ever on how people age and live well....
Understanding GLP-1 Side Effects Through a Nutritional Lens
GLP-1 medications have changed the landscape of weight management. For many people, they have delivered clinically meaningful weight loss alongside improvements in glycaemic control, and their place in treatment pathways is now well established. What is becoming...
PICTURE: Democratising Clinical Intelligence from the Frontline
A New Era for EHR Data A new study published in the latest issue of the Royal College of Physicians’ Future Healthcare Journal introduces PICTURE, an innovative data platform designed to convert routine electronic health record (EHR) data into actionable clinical...
European Life Sciences: Rethinking the “Organic” US Expansion
Against a backdrop of rising development and launch costs, growing regulatory complexity, geopolitical uncertainty and intensifying competition for specialist talent, many European pharma and biotech companies are reassessing the long-held ambition of “cracking the...
Professor Chris Van Tulleken to Headline Smart Ageing Summit in May
After the success of previous summits, the revolutionary Smart Ageing Summit has announced a return to Oxford this May to host its fourth annual event. Rhodes House, University of Oxford is the perfect setting for non-profit organisation Oxford Health Project to host...
J&J to Invest Over $1B in Pennsylvania Cell Therapy Manufacturing Facility
Johnson & Johnson has announced plans to invest more than $1 billion in a new cell therapy manufacturing facility in Montgomery County, Pennsylvania. This project marks a significant expansion of its advanced therapies infrastructure and reinforces the company’s...
UK Expertise: Faster Cancer Diagnosis and Cleaner Energy
British research expertise to deliver faster cancer diagnosis and cleaner energy Major new backing for medical imaging centres across the UK alongside tidal energy testing expansion in Orkney and cutting-edge materials. From: Department for Science, Innovation and...
NIH Scientists Pioneer “Digital Twin” of Eye Cells
NIH Scientists Pioneer “Digital Twin” of Eye Cells: A New Frontier in Treating Age-Related Macular Degeneration In a landmark achievement for computational biology and ophthalmology, researchers at the National Institutes of Health (NIH) have announced the development...
The Evidence Behind Fertility Supplements: What the Research Actually Shows
Couples trying to conceive are bombarded with supplement recommendations. Scroll through any fertility forum and you'll find confident claims about CoQ10, vitamin D, and a dozen other compounds that supposedly hold the key to conception. Some of these recommendations...
Prices for GLP-1 Drugs Are Falling Fast and Forcing Companies to Adapt
The global market for GLP-1 receptor agonists, once defined by scarcity and premium pricing, is entering a new phase. Prices for these blockbuster medicines, used to treat obesity and type 2 diabetes, are beginning to fall rapidly, forcing pharmaceutical companies,...
AuDHD: Rethinking the Overlap Between Autism and ADHD
A Diagnostic Separation That Shaped a Generation For most of the modern history of psychiatry, autism and ADHD were treated as mutually exclusive conditions. Clinicians were trained to look for one or the other. Until the publication of DSM-5 in 2013, a dual diagnosis...
Australian Healthcare Reviews Mean Nothing Without the Right Governance
Australians are making some of their most important healthcare decisions based on information that was never designed to carry that weight. For most Australians, searching for health information online and accessing test results digitally is already routine. Around 90...
GMCA: Why Unlocking Longevity Research Will Drive Innovation
The science of longevity has never been more active. With advances in preventive medicine and digital health, as well as new insights into lifestyle, environment, drug therapies and genetics, there is more research available than ever on how people age and live well....
Understanding GLP-1 Side Effects Through a Nutritional Lens
GLP-1 medications have changed the landscape of weight management. For many people, they have delivered clinically meaningful weight loss alongside improvements in glycaemic control, and their place in treatment pathways is now well established. What is becoming...
PICTURE: Democratising Clinical Intelligence from the Frontline
A New Era for EHR Data A new study published in the latest issue of the Royal College of Physicians’ Future Healthcare Journal introduces PICTURE, an innovative data platform designed to convert routine electronic health record (EHR) data into actionable clinical...
European Life Sciences: Rethinking the “Organic” US Expansion
Against a backdrop of rising development and launch costs, growing regulatory complexity, geopolitical uncertainty and intensifying competition for specialist talent, many European pharma and biotech companies are reassessing the long-held ambition of “cracking the...
Professor Chris Van Tulleken to Headline Smart Ageing Summit in May
After the success of previous summits, the revolutionary Smart Ageing Summit has announced a return to Oxford this May to host its fourth annual event. Rhodes House, University of Oxford is the perfect setting for non-profit organisation Oxford Health Project to host...
J&J to Invest Over $1B in Pennsylvania Cell Therapy Manufacturing Facility
Johnson & Johnson has announced plans to invest more than $1 billion in a new cell therapy manufacturing facility in Montgomery County, Pennsylvania. This project marks a significant expansion of its advanced therapies infrastructure and reinforces the company’s...
UK Expertise: Faster Cancer Diagnosis and Cleaner Energy
British research expertise to deliver faster cancer diagnosis and cleaner energy Major new backing for medical imaging centres across the UK alongside tidal energy testing expansion in Orkney and cutting-edge materials. From: Department for Science, Innovation and...
NIH Scientists Pioneer “Digital Twin” of Eye Cells
NIH Scientists Pioneer “Digital Twin” of Eye Cells: A New Frontier in Treating Age-Related Macular Degeneration In a landmark achievement for computational biology and ophthalmology, researchers at the National Institutes of Health (NIH) have announced the development...
The Evidence Behind Fertility Supplements: What the Research Actually Shows
Couples trying to conceive are bombarded with supplement recommendations. Scroll through any fertility forum and you'll find confident claims about CoQ10, vitamin D, and a dozen other compounds that supposedly hold the key to conception. Some of these recommendations...
Prices for GLP-1 Drugs Are Falling Fast and Forcing Companies to Adapt
The global market for GLP-1 receptor agonists, once defined by scarcity and premium pricing, is entering a new phase. Prices for these blockbuster medicines, used to treat obesity and type 2 diabetes, are beginning to fall rapidly, forcing pharmaceutical companies,...
AuDHD: Rethinking the Overlap Between Autism and ADHD
A Diagnostic Separation That Shaped a Generation For most of the modern history of psychiatry, autism and ADHD were treated as mutually exclusive conditions. Clinicians were trained to look for one or the other. Until the publication of DSM-5 in 2013, a dual diagnosis...
Featured Articles
Further News
FDA Approves Commercial Manufacturing at Rezon Bio
Rezon Bio announces that its Warsaw-Duchnice facility has received approval from the U.S. Food and Drug Administration (FDA) for the commercial manufacturing of a biosimilar. This milestone represents an important step in the continued development of Rezon Bio's...
Doctors Warn AI Diet Advice Should Not Replace Medical Care
As more people turn to AI tools and online algorithms for diet and weight-loss advice, doctors are warning that this growing reliance may be overlooking critical health risks. Doctors stress that AI-generated information should never replace personalised medical...
Fertility Decisions and AI: Clarity Without False Certainty
As a researcher studying how people interact with large language models (LLMs), and as a clinician trained at the master’s level in clinical psychology, I keep seeing the same pattern in fertility and reproductive contexts. People rarely turn to AI only for...
Uniphar | Clinical merges with BMclinical
Leading global healthcare services provider Uniphar announces a strategic merger between Uniphar | Clinical and BMclinical, reinforcing Uniphar | Clinical’s integrated clinical supply offering and solidifying its position as a trusted partner to pharmaceutical and...
AI-Enabled Pathology: De-risking Oncology Drug Development
Today, oncology drug development continues to experience the highest attrition rates across therapeutic areas[1]. Despite major advances in molecular profiling and biomarker-driven strategies, a significant proportion of oncology clinical trials still fail, often due...
Why Sugar May Matter More Than We Thought
A New Energy-Centered Model of Metabolic Disease For decades, sugar has been framed as a problem of excess. Too many calories. Too many insulin spikes. Too much sweetness in the modern diet. That framing has shaped public health guidance, food reformulation, and...
Cera and Promptly Health Partner to Bridge the ‘Evidence Gap’
Cera, Europe’s largest digital-first home healthcare provider, has announced a global real-world evidence (RWE) partnership with Promptly Health, focused on the over-65s, to accelerate drug development and enable precision medicine. The partnership integrates Cera’s...
From Hype to Hard Science: Unlocking MSC Therapy’s Promise
After decades of promise and setbacks, advanced manufacturing platforms and robust Phase 2/3 trials are demonstrating whether MSCs can deliver transformative treatments for high-burden diseases Mesenchymal stromal cells (MSCs) have been called the most promising...
RCM Efficiency: Solving Insurance Denials & Margin Pressure
Insurance Denials and Revenue Cycle Inefficiencies Are Becoming a Primary Driver of Hospital Financial Strain U.S. hospitals are entering the next fiscal cycle under sustained financial pressure, and insurance denials have emerged as one of the most consequential, yet...
Thousands Recruited for “New Era” Severe Mental Illness Study
Thousands of people living with schizophrenia and severe depression are being recruited by the NHS for a major new study which could unlock a “new era” of personalised treatment for severe mental illness. As part of the world’s largest mental health study, researchers...
THX Pharma and Biocodex Sign Licensing Deal for Batten-1 and TX01 Therapies
THX Pharma (formerly known as Theranexus) has entered into a strategic licensing agreement with French pharmaceutical company Biocodex covering two experimental programs, Batten-1 and TX01, in a move aimed at accelerating development and expanding commercial reach....
Chronic Pain and Neuroplastic Pain: Rethinking How Pain is Created
Chronic pain affects hundreds of millions of people worldwide and remains one of the most challenging problems in modern medicine. For decades, pain has largely been understood as a direct signal of tissue damage or disease. However, advances in pain science are...
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.